Nonsteroidal Anti-Inflammatory Drugs and the Kidney
Hörl, Walter H.·2010·Pharmaceuticals
Cites (242)
Items 201–232 of 232
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Blood PressureGustavo A. Fierro-Carrion, C. Venkata S. Ram · 1997 · The American Journal of Cardiology
- PASSOVOY FACTOREugene A. Beck · 1975 · The Lancet
- Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: Possible role of TGFβAndré Schneider, Friedrich Thaiss, Hans-Peter Rau, Günter Wolf, Gunther Zahner, Thomas Jocks, Udo M. Helmchen, Rolf A.K. Stahl · 1996 · Kidney International
- Increased salt retention and hypertension from non-steroidal agents in the elderlyEamon C. Mulkerrin · 1997 · QJM
- Indomethacin Enhances Shuttling of Aquaporin-2 Despite Decreased Abundance in Rat KidneySoo Wan Kim, Joon Wan Kim, Ki Chul Choi, Seong Kwon, YoonWha Oh, Ju‐Young Jung, Jin Kim, Jong‐Un Lee · 2004 · Journal of the American Society of Nephrology
- Regional Expression of Cyclooxygenase Isoforms in the Rat Kidney in Complete Unilateral Ureteral ObstructionShyan–Yih Chou, Hui Cai, DAVID PAI, M Mansour, PAUL HUYNH · 2003 · The Journal of Urology
- Interaction of Prostaglandins and Angiotensin II in the Modulation of Renal Function in Congestive Heart FailureMilton Packer · 1989 · The Journal of Urology
- Reversible Acute Decrease in Renal Function by NSAIDs in CirrhosisD. Craig Brater, Shirley A. Anderson, Debbie Brown–Cartwright · 1987 · The American Journal of the Medical Sciences
- Indomethacin induces free radical-mediated changes in renal brush border membranesJayasree Basivireddy, M. Jacob, K.A. Balasubramanian · 2005 · Archives of Toxicology
- Nonsteroidal antiinflammatory drug toxicity monitoring and safety practices.Fausto G. Patino, Jason J. Olivieri, Jeroan J. Allison, Ted R. Mikuls, Larry W. Moreland, Stacey H. Kovac, Lucia Juarez, Sharina D. Person, Jeffrey R. Curtis, Kenneth G. Saag · 2003 · PubMed
- Renal effects of oral prostaglandin supplementation after ibuprofen in diabetic subjectsGeorge L. Bakris, Uwe Starke, Michael Heifets, Donovan C. Polack, M Smith, Sue E. Leurgans · 1995 · Journal of the American Society of Nephrology
- The prevalence of cardiorenal risk factors in patients prescribed nonsteroidal anti-inflammatory drugs: Data from managed careCR Harley · 2003 · Clinical Therapeutics
- Changes in Residentsʼ Attitudes in Response to Residency Program Modifications: A Prospective StudyCharles B. Seelig · 1992 · Southern Medical Journal
- Syncope Caused by Nonsteroidal Anti-Inflammatory Drugs and Angiotensin-Converting Enzyme InhibitorsChinori Kurata, Akihiko Uehara, Toshihiko Sugi, Keisuke Yamazaki · 1999 · Japanese Circulation Journal-english Edition
- Indomethacin and the Nephrotic SyndromeIsam H. Shehadeh · 1979 · JAMA
- Renal papillary necrosis due to naproxen.Caruana Rj, E L Semble · 1984 · PubMed
- Benoxaprofen and papillary necrosis.L Erwin, Judy M. Jones · 1982 · BMJ
- Patient benefit-risk in arthritis--a rheumatologist's perspectiveJ. W. J. Bijlsma · 2010 · Lara D. Veeken
- Dehydration-induced increase in aquaporin-2 protein abundance is blocked by nonsteroidal anti-inflammatory drugsErin Baggaley, Søren Møller Nielsen, David D.R. Marples · 2010 · American Journal of Physiology-Renal Physiology
- Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletionThomas Kistler, PM Ambühl · 2001 · Swiss Medical Weekly
- Low sodium and furosemide–induced stimulation of the renin system in man is mediated by cyclooxygenase 2Martin Kammerl · 2001 · Clinical Pharmacology & Therapeutics
- Effect of inhibitors of prostaglandin synthesis on the furosemide action in the loop Henle of rat kidneyJOACHIM GREVEN, A. Farjam · 1988 · Pflügers Archiv - European Journal of Physiology
- Acute Effects of the Anti-Inflammatory Cyclooxygenase-2 Selective Inhibitor, Flosulide, on Renal Plasma Flow and Glomerular Filtration Rate in RatsÀngels Turull, Carlos Piera, Josep Queralt · 2001 · Inflammation
- Arthritis Is Associated With Cardiovascular Disease in the Users of Analgesics and Nonsteroidal Anti-inflammatory DrugsFakhreddin Jamali · 2007 · Archives of Internal Medicine
- Safety of Short-Term Administration of Celecoxib in Decompensated Cirrhosis *Mical S. Campbell, George A. Makar · 2005 · Hepatology
- The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effectsHeinrich Knauf, Matthew A. Bailey, Gerd P Hasenfuss, E. Mutschler · 2006 · European Journal of Clinical Pharmacology
- Cyclooxygenase 2 inhibition exacerbates AQP2 and pAQP2 downregulation independently of V2 receptor abundance in the postobstructed kidneyAnja Møller Jensen, Eun Hui Bae, Rikke Nørregaard, Guixian Wang, Søren Steen Nielsen, Horst Schweer, Soo Wan Kim, Jørgen Frøkiær · 2010 · American Journal of Physiology-Renal Physiology
- An Ion Channel Hypothesis to Explain Divergent Cardiovascular Safety of Cyclooxygenase-2 Inhibitors: The Answer to a Hotly Debated Puzzle?Mark S. Shapiro · 2009 · Molecular Pharmacology
- Comparison of Staging Systems for HCC: One More Positive Answer or Mission Impossible? *Teh‐Ia Huo, Jaw‐Ching Wu, Shou‐Dong Lee · 2005 · Hepatology
- Indomethacin decreases furosemide-induced natriuresis and diuresis on the neonatal kidneyJose Luis Reyes, Irma Aldana, Olivier Christophe Barbier, Arlen A. Parrales, María Estela Meléndez-Camargo · 2006 · Pediatric Nephrology
- Effect of indomethacin and selective cyclooxygenase‐2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosisSerdar Kahvecioğlu, Kamıl Dilek, İbrahim Akdağ, Mustafa Güllülü, Celalettin Demircan, Alpaslan Ersoy, Mustafa Yurtkuran · 2006 · Nephrology
- Safety of Short-Term Administration of Celecoxib in Decompensated Cirrhosis *Joan Clària, Vicente Arroyo · 2005 · Hepatology